About Shukrapharmaceuticals
Shukrapharmaceuticals is a company. The company has 115 employees as of March 31, 2024.
- Employees 115 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Shukra Pharmaceuticals Ltd.
-
Annual Revenue
$3.81 M (USD)-56.3as on Mar 31, 2025
-
Net Profit
$1.12 M (USD)-48.35as on Mar 31, 2025
-
EBITDA
$1.49 M (USD)-34.48as on Mar 31, 2025
-
Latest Funding Round
-
Investors
-
Employee Count
115
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Shukrapharmaceuticals
Shukrapharmaceuticals is a publicly listed company on the BSE with ticker symbol SHUKRAPHAR in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Shukrapharmaceuticals
Unlock access to complete
Unlock access to complete
Funding Insights of Shukrapharmaceuticals
Investments & Acquisitions by Shukrapharmaceuticals
Financial Statements - Shukrapharmaceuticals
Shukrapharmaceuticals Comparisons
Competitors of Shukrapharmaceuticals
Frequently Asked Questions about Shukrapharmaceuticals
As of Mar 31, 2024, the latest employee count at Shukrapharmaceuticals is 115.
Annual revenue of Shukrapharmaceuticals is $3.81M as on Mar 31, 2025.
Generic medications are developed and produced by Shukrapharmaceuticals in the pharmaceutical sector, with emphasis on cost-effective methods. Manufacturing processes are aligned with strict quality controls, and regulatory approvals are obtained across international markets. The product lineup features injectables, oral solids, and capsules. Distribution efforts support healthcare access in various regions, though specific founding details remain unavailable.
Yes, Shukrapharmaceuticals is publicly traded on BSE under the ticker symbol SHUKRAPHAR.
The ticker symbol of Shukrapharmaceuticals is SHUKRAPHAR on BSE.